Screener
United Therapeutics UTHR Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
FAQ
- What is United Therapeutics's interest expense?
- United Therapeutics (UTHR) reported interest expense of $2.9M in Q2 2026.
- How has United Therapeutics's interest expense changed year-over-year?
- United Therapeutics's interest expense decreased by 60.3% year-over-year, from $7.3M to $2.9M.
- What is the long-term trend for United Therapeutics's interest expense?
- Over 3 years (2022 to 2025), United Therapeutics's interest expense has grown at a -15.6% compound annual growth rate (CAGR), from $32.4M to $19.5M.
- What does interest expense mean?
- Interest expense as reported by United Therapeutics Corp.
Ask your AI about United Therapeutics's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude